Clinical Trials
6
Active:3
Completed:3
Trial Phases
1 Phases
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (100.0%)Study to Evaluate Safety and Efficacy of Inhaled Bimosiamose for the Treatment of Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Phase 2
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2010-04-22
- Last Posted Date
- 2011-05-09
- Lead Sponsor
- Revotar Biopharmaceuticals AG
- Target Recruit Count
- 60
- Registration Number
- NCT01108913
- Locations
- 🇩🇪
Insaf - Respiratory Research Institute GmbH, Wiesbaden, Germany
Study to Evaluate the Effect of Bimosiamose on Ozone Induced Sputum Neutrophilia
Phase 2
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-08-20
- Last Posted Date
- 2010-01-06
- Lead Sponsor
- Revotar Biopharmaceuticals AG
- Target Recruit Count
- 18
- Registration Number
- NCT00962481
- Locations
- 🇩🇪
Pneumologisches Forschungsinstitut GmbH am Krankenhaus Großhansdorf, Großhansdorf, Germany
Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis
- First Posted Date
- 2009-01-16
- Last Posted Date
- 2009-08-21
- Lead Sponsor
- Revotar Biopharmaceuticals AG
- Target Recruit Count
- 107
- Registration Number
- NCT00823693
- Locations
- 🇩🇪
Charité Campus Mitte, Klinik für Dermatologie, Venerologie und Allergologie, Berlin, Germany
News
No news found